Pest resistance threatens corn industry's newest biotech defense, study warns

Corn rootworms, pests responsible for billions of dollars in yearly crop losses, are evolving resistance that weakens even ...

RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies | DataM Intelligence

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to ...

Does Alnylam Pharmaceuticals (ALNY) Have the Potential to Generate Strong Long-Term Growth?

Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Growth Fund” second quarter 2025 ...

DataM Intelligence 4 Market Research LLP: RNA-based Therapies Market to Reach USD 213.54 Billion by 2033, Driven by Rare Diseases, Oncology, and Advances in RNA Technologies ...

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to reach USD ...

How Ants Maintain One Receptor, One Neuron for Smell

Ants rely on pheromones to coordinate their societies, but how do their neurons avoid sensory confusion? Researchers studying ...

Is Alnylam Pharmaceuticals (ALNY) an Undervalued Stock?

PGIM, an investment management company, released its “PGIM Jennison Health Sciences Fund” second-quarter 2025 investor letter ...
AgriBusiness Global

GreenLight Biosciences Launches Norroa, the First RNA-Based Treatment for Varroa Mites

GreenLight Biosciences has announced the U.S. Environmental Protection Agency’s (EPA) registration of Norroa, the first-ever nature-based treatment specifically designed to combat varroa mites, the ...

AI unlocks RNA’s role in Dementia and emerging viral threats

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...